Author
The Francis Crick InstituteORCID 0000-0002-1428-9621Unclaimed ORCID profile · follow to get notified of new preprints
7 papers
Recent·Most cited
Ruth Harvey, Tiphaine Cayol, Basudev Paudyal…·Elma Z. Tchilian
This study compares antigenic profiles of post-infection antisera from pigs and ferrets against human influenza A(H1N1pdm09) viruses, finding similar reactivity but limitations in detecting antigenic drift variants.
Björn F. Koel, Alexander Byrne, Samuel A. Turner…·Ron A. M. Fouchier
This study characterizes the emergence and antigenic properties of influenza A(H3N2) viruses with N158K and K189R substitutions, showing they are antigenically distinct from vaccine strains and may reduce vaccine effectiveness.
I-Ting Tu, Christina Lynggaard, Lorin Adams…·Daniel G. Streicker
This study identifies H5 influenza virus infections in vampire bats, showing their potential to spread the virus between marine and terrestrial ecosystems.
Jumpei Ito, Shusuke Kawakubo, Hiroaki Unno…·Kei Sato
This study uses a protein language model to map influenza virus antigenicity from genotype data, revealing evolutionary patterns and improving vaccine strain selection.
Carmen Figueras-Novoa, Lewis Timimi, Elena Marcassa…·Rupert C. L. Beale
This study shows SARS-CoV-2 E protein induces LC3 lipidation through the V-ATPase-ATG16L1 axis, which supports viral replication rather than inhibiting it.
Caroline Kikawa, John Huddleston, Andrea N. Loes…·Jesse D. Bloom
The paper quantifies neutralizing antibody responses to influenza strains using sera collected in 2024-2025 to inform vaccine-strain selection for 2025.
Giulia Dowgier, Agnieszka Hobbs, David Greenwood…·Mary Y Wu
The paper evaluates neutralising antibody titres against SARS-CoV-2 variant JN.1 using live-virus microneutralisation assays in vaccinated individuals, finding higher titres in monovalent vaccine recipients.